# Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors

> **NCT03035409** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **M.D. Anderson Cancer Center** · enrollment: 129 (actual)

## Conditions studied

- Advanced Malignant Solid Neoplasm
- C-Reactive Protein Measurement
- Cancer Fatigue
- Metastatic Malignant Solid Neoplasm
- Recurrent Malignant Solid Neoplasm
- Weight Loss

## Interventions

- **DRUG:** Anamorelin Hydrochloride
- **BEHAVIORAL:** Exercise Intervention
- **OTHER:** Laboratory Biomarker Analysis
- **OTHER:** Nutritional Assessment
- **OTHER:** Quality-of-Life Assessment
- **OTHER:** Questionnaire Administration

## Key facts

- **NCT ID:** NCT03035409
- **Lead sponsor:** M.D. Anderson Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-02-08
- **Primary completion:** 2019-12-27
- **Final completion:** 2026-02-28
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2025-11-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03035409

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03035409, "Anamorelin Hydrochloride, Physical Activity, and Nutritional Counseling in Decreasing Cancer-Related Fatigue in Patients With Incurable Metastatic or Recurrent Solid Tumors". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03035409. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*